Jury Hands Endo Win In Opana Pay-For-Delay Case
An Illinois jury sided with Endo Pharmaceuticals on Friday over allegations that it struck an unlawful settlement with Impax Laboratories to delay a generic version of Endo's Opana ER painkiller, finding...To view the full article, register now.
Already a subscriber? Click here to view full article